Antiepileptic (sodium channel blocker)
Lamotrigine in Japan: prescription, brands, pricing
This page summarises the situation of Lamotrigine in Japan under PMDA (Pharmaceuticals and Medical Devices Agency): prescription status, available brands and generics, pharmacy dispensing, and online options in JPY. Lamotrigine belongs to the Antiepileptic (sodium channel blocker) class.
- Regulator
- PMDA (Pharmaceuticals and Medical Devices Agency)
- Currency
- JPY
About Lamotrigine
Lamotrigine is approved in adults and children aged 2 years and older as adjunctive or monotherapy for partial-onset seizures, primary generalised tonic-clonic seizures and seizures associated with Lennox-Gastaut syndrome. Japan classifies medicines into prescription drugs (医療用医薬品) and OTC drugs (一般用医薬品), the latter further divided into pharmacist-only (第1類) and self-service classes. The Ministry of Health, Labour and Welfare (MHLW) sets the regulatory framework; PMDA reviews safety and efficacy.
Mechanism and action
Lamotrigine is a phenyltriazine that selectively blocks voltage-gated sodium channels, stabilising neuronal membranes and reducing the release of excitatory neurotransmitters, particularly glutamate.
Brands and generics in Japan
In Japan, Lamotrigine is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Japanese pharmacies (薬局) and drugstores (ドラッグストア) such as Matsumoto Kiyoshi and Welcia are widespread. Prescription dispensing pharmacies (調剤薬局) are usually located near hospitals and clinics; pharmacist counselling at dispensing is mandated by the Pharmaceutical Affairs Law. Brand-to-generic substitution is decided by the pharmacist under local PMDA (Pharmaceuticals and Medical Devices Agency) equivalence rules, and the price difference in JPY is usually substantial.
Online and tele-prescribing access
Japan permits online sale of most OTC medicines under the 2014 amendments to the Pharmaceutical Affairs Law, with class-based restrictions. Online prescription dispensing is allowed via licensed pharmacies after a face-to-face or telemedicine consultation; personal importation of prescription medication is restricted to limited quantities for personal use. For Lamotrigine specifically, the legal online options in Japan depend on its Rx-or-OTC classification under PMDA (Pharmaceuticals and Medical Devices Agency).
Frequently asked questions
Is Lamotrigine available in Japan? ▾
Yes — Lamotrigine and its brands are available in Japan through pharmacies authorised by PMDA (Pharmaceuticals and Medical Devices Agency), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Lamotrigine in Japan? ▾
Japan classifies medicines into prescription drugs (医療用医薬品) and OTC drugs (一般用医薬品), the latter further divided into pharmacist-only (第1類) and self-service classes. The Ministry of Health, Labour and Welfare (MHLW) sets the regulatory framework; PMDA reviews safety and efficacy. The exact status of Lamotrigine (Rx or OTC) is determined by PMDA (Pharmaceuticals and Medical Devices Agency); most active ingredients in the Antiepileptic (sodium channel blocker) class require prescription, although there are exceptions by country and formulation.
How much does Lamotrigine cost in Japan? ▾
The price in JPY depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Lamotrigine in Japan
Lamotrigine in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.